Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6046159 | Preventive Medicine | 2016 | 41 Pages |
Abstract
The evidence does not support CXR screening with or without sputum cytology for lung cancer. High quality evidence showed that in selected high-risk individuals, LDCT screening significantly reduced lung cancer mortality and all-cause mortality. However, for its implementation at a population level, the current evidence warrants the development of standardized practices for screening with LDCT and follow-up invasive testing to maximize accuracy and reduce potential associated harms.
Keywords
KFSMSKMLPNLSNLSTCXRPLCOUSPSTFJHSLSSLDCTGrading of Recommendations Assessment, Development and EvaluationLow-dose computed tomographyDanteChest radiographyLung cancerSputum cytologyMILDScreeningNational lung screening trialPrimary health careSystematic reviewGradeNELSONUnited States Preventive Services Task ForceProstate, Lung, Colorectal and Ovarian Cancer Screening Trial
Related Topics
Health Sciences
Medicine and Dentistry
Complementary and Alternative Medicine
Authors
Muhammad Usman Ali, John Miller, Leslea Peirson, Donna Fitzpatrick-Lewis, Meghan Kenny, Diana Sherifali, Parminder Raina,